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Summary.-ICRF 159 has been shown to increase the X-radiation sensitivity of
exponentially growing EMT6 mouse tumour cells in vitro. This was found only with
ICRF 159 exposure times longer than 10 h and only when the drug was given before
irradiation. The increase in radiation sensitivity was expressed as a reduction of the
shoulder of the radiation survival curve.
As ICRF 159 was shown to have no effect on the repair of sub-lethal radiation
damage, it was concluded that the drug reduced the capacity to accumulate such
damage. ICRF 159 was also shown to have no effect on the repair of potentially lethal
radiation damage in late plateau cells.
PRIOR treatment for 24 h with the anti-
mitotic agent ICRF 159 was found to
increase the effects of X-rays on EMT6
cells grown in vitro (Taylor and Bleehen,
1977). This potentiation was seen to be
dependent on the number of proliferating
cells in the drug-treated cell population.
Cells in the exponential phase of growth
when treated with ICRF 159, were found
to have a much reduced radiation survival-
curve shoulder.
In this paper we have examined the
time course of this effect and investigated
interactions between ICRF 159 and repair
processes associated with cellular radiation
damage.
MATERIALS AND METHODS
The cell line.-The cells used in this study
wereEMT6/M/CC. Cells werecultured in 35 ml
plastic flasks (Nunc U.K. Ltd) containing
5 ml of Eagles MEM supplemented with 20%
calf serum and gassed with a mixture of95%
air and 5% Co2. Flasks for exponential-
phase cultures were seeded with 3-5 x 104
cells and allowed to grow, undisturbed, for
48 h before treatment began. In all experi-
ments to be described, exponential-phase
cultures were used unless otherwise stated.
The in vitro proliferation kinetics of this cell
line have been fully described (Twentyman
et al., 1975).
Radiation treatment.-Irradiations were
carried out using 250 kV X-rays from a
Pantak machine, with a dose rate of about
63 rad/min. The cells were irradiated at room
temperature whilst covered with medium and
attached to the surface of the flasks. In the
split-dose experiments the cells were returned
to the incubator between irradiations.
ICRF 159 treatment.-A quantity of ICRF
159 was dissolved in 0-4M HCI to produce a
solution 50x the final concentration required
in the culture flasks. This stock solution was
sterilized by millipore filtration and 01 ml
was then added to each of the experimental
flasks. 01 ml of 0-4M HCI was added to
control flasks. In all experiments to be
described a drug dose of 200 jug/ml was used.
Survival assay.-Immediately after final
irradiation or ICRF 159 treatment, the cells
were removed from the surface ofthe flask by
15 min incubation with 0-075% trypsin
solution. Two washes were used to ensure
adequate removal of the drug. Following
resuspension in medium, the cells were
counted in a haemocytometer. After the
appropriate dilutions were made, the cells
were plated into 50 mm plastic culture dishes
(Sterilin). These were incubated at 37°C for
10 days in plastic boxes gassed with 95% airI. W. TAYLOR AND N. M. BLEEHEN
and 5% CO2 and at high humidity. Survival
was determined at the end of this time by
fixing and staining the cells and then counting
colonies containing 50 or more cells.
RESULTS
All points shown in theFiguresrepresent
a surviving fraction estimated from the
mean colony count on 4 replicate dishes.
The errors associated with individual
determinations were small compared with
the spread of results between separate
determinations. Where sample errors have
been shown, these have been calculated
from the Poisson variance as described by
Boag (1975). The errors shown in Table I
are for the aggregated results and are
calculated from the regression analysis.
Single-dose radiation response
(a) ICRF 159 before irradiation.-In all
experiments with pretreatment by ICRF
159, the cells are exposed to the drug
before and during irradiation.
We have previously shown that the
radiation response of untreated exponen-
tial cultures (Fig. 1) is characterized by a
wide shoulder with a high extrapolation
number (n = 51) and a Dq of 509 rad
(Taylor and Bleehen, 1977). A 24h
exposure to ICRF 159 before irradiation
(Fig. 1) reduces the width ofthe shoulder,
giving a lower extrapolation number
(n - 3) and a reduced Dq (129 rad). If,
however, the time of pretreatment with
ICRF 159 is reduced to 6 h as in the
present series of experiments (Fig. 1), the
observed radiation response is not found
to be significantly different from no-drug
controls. Neither a 6h nor a 24h drug
treatment has any significant effect on the
slope (Do) ofthe radiation response curve.
To demonstrate whether ICRF 159 has
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FIG. 1. Change in surviving fraction of
exponential-phase cultures of EMT6 cells
with dose of X-rays. Upper solid line: X-
rays alone. Solid circles (and lower solid
line): cells exposed to ICRF 159 (200 ,ug/ml)
6 h before X-irradiation. Interrupted line:
ICRF 159 (6 h) + X-irradiation, normalized
to unity. Dotted line: ICRF 159(200,ug/ml)
24 h before X-irradiation, normalized to
unity. Datum points for X-irradiation
alone and for 24 h ICRF 159 + X-irradia-
tion curves have been shown in a previous
communication (Taylor and Bleehen, 1977).
Exponential portion of curves fitted by
regression analysis, shoulder portion drawn
by eye.
an additive or a potentiating effect on the
radiation response, the curves showing the
combined treatment (Fig. 1) were nor-
malized to unity to account for the drug
cytotoxicitv. Values of n, Do and Dq for
the combined treatments are shown in the
Table and were calculated from the
normalized curves.
TABLE.-Computed Parameters of Radiation-response Data
Treatment D. (rad) n Dq (rad)
s alone* 129 (114-148) 51 (18-147) 509
gl/ml ICRF 159 109 (101-118) 79 (40-153) 478
6 h before X-rays
200 ,tg/ml ICRF 159* 114 (94-
24 h before X-rays
* Taylor and Bleehen, 1977.
95% confidence limits in parentheses.
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FIG. 2.-Change in surviving fraction of
exponential-phase cultures of EMT6 cells
with time after administration ofICRF 159
(200 jig/ml). Opencircles: ICRF 159-treated
cells. Closed circles: ICRF 159 treatment
followed by X-irradiation (675 rad).
Interrupted line: ICRF 159 + X-irradia-
tion normalized to account for drug
cytotoxicity. Lines drawn by eye. i -arith-
metic mean ± 2 s.e.
To determine the time sequence of the
radiation potentiation, arangeofICRF 159
exposure times (from 1 to 24 h) followed
by a single dose ofradiation was examined
(Fig. 2). The radiation dose used (675 rad)
gave cell survivals on the exponential
portion of the control or drug-treated
radiation survival curves (Fig. 1).
The changes in surviving fraction in
Fig. 2, therefore, reflect quantitative
changes in the shoulder of the radiation-
response curve. The interrupted line, as
before, shows the combined treatment
results normalized to account for the drug
cytotoxicity. Drug-exposure times of 1-
10h before X-rays appear to have little
effect on the radiation response. The
normalized surviving fraction declines
from 0-25 to 0-17 in this time. However,
with pretreatment times from 10 to
16 h an exponential decline in surviving
fraction is observed, from 0 17 at 10 h to
0-01 at 16 h. On increasing the drug-
exposure time from 16 to 24 h, no further
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FIG. 3.-Change in surviving fraction of
exponential-phase cultures of EMT6 cells
with dose of X-rays. Solid line: X-irra-
diation alone (see text). Symbols represent
ICRF 159 exposures after X-irradiation
(normalized to unity). 0, 0-2 h; A, 0-6 h;
O, 0-16h; *, 0-24h.
decrease in surviving fraction with time
is found.
(b) ICRF 159 after irradiation.-Fig. 3
shows the radiation response of cells
exposed to ICRF 159 immediately (within
1-2 min) after irradiation. Drug-exposure
times of 2, 6, 16 and 24 h were used. Cells
not exposed to ICRF 159 were similarly
irradiated, the flasks being left for equi-
valenttimesaftertreatment, beforetypsin-
izing and plating out. The subsequent
surviving fractions for the control (no drug
treatment) cells were found to lie on or
close to the normal radiation response
curve. These have not been shown here,
for clarity. The surviving fractions for the
drug-treated cells have been normalized to
account for the variation in cytotoxicity
with time. The combined treatment in this
situation appears to be no more than
additive.
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Two-dose radiation response
Fig. 2 shows that no change in the
radiation response with time is observed
with drug-exposure times of 1-10 h, and
the combined treatment is no more than
additive. Similarly, with drug-exposure
times of 16-24 h, no change in the
radiation response with time is seen, but
the combined treatment has agreater than
additive effect. In a series of split-dose
experiments we compared the ability of
cells to repair sub-lethal damage after drug
exposure of 6 or 24 h, with non-drug
controls. Two equal radiation doses were
used in each experiment, each dose being
equivalent to about 1-5 x Dq measured
for the appropriately treated cells (Table).
Forthe 6h drug exposure, the second of
the 2 radiation doses was given at 6 h, the
first being given at varying times before,
depending ontherequiredintervalbetween
the radiation doses. The drug was always
present at the time of the first radiation
dose. Therefore, the maximum interval
between doses examined was 6 h. Cells
exposed to ICRF 159 for 24 h were treated
similarly, again with a maximum interval
of 6 h between radiation doses. Both
fractions of the split radiation doses were
given within the respective temporal
limits of the 2 plateau regions shown in
Fig. 2. The results ofthese experiments are
shown in Fig. 4.
Recovery was calculated in thefollowing
manner. The single radiation dose (D)
giving the same surviving fraction as that
found from a split-dose regime was
calculated from Fig. 1. This value was
then subtracted from the total dose
(Dl + D2)givenastwofractions. (D1 +D2)
-D, therefore, is a measure of recovered
dose. The recovered dose was then ex-
pressed as a percentage ofthe appropriate
Dq (Table)
Percentage recovery -
(Di + D2)- D X 100.
Dq
It is apparent that no reduction in the
capacity to repair sub-lethal radiation
damage is observed with either a 6-h
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FIG. 4.-Change in percentage recovery (see
text) ofexponential-phase cultures ofEMT6
cells with interval between 2 doses of X-
rays. 0, radiation alone; A, cells exposed
to ICRF 159 (200 ,g/ml) for 6 h; 0, cells
exposed to ICRF 159 (200 jug/ml) for 24 h.
Drug exposures encompass the split-dose
X-irradiation. Line drawn by eye.
or a 24h drug treatment, when compared
to controls. Both control and drug-treated
cell populations recover -.,80% of their
radiation survival-curve shoulder, as mea-
sured by Dq, in about 6 h.
Effect of delayed subculture
Under certain conditions, repair of
sub-lethal radiation damage can be aug-
mented by repair of a second type of
radiation damage, that of potentially
lethal damage (PLD) (Little et al., 1973).
This can be observed after a single
exposure to radiation, when the irradiated
cells are subject to conditions which
inhibit the normal progression of cells
through the proliferative cycle (Phillips
and Tolmach, 1966). This type ofradiation
repair is not normally found in exponen-
tially growing cells. However, 200 ,ug/ml
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FIG. 5. Change in surviving fraction of
exponential-phase cultuires of EMT6 cells
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Fie. 6. Change in surviving fIractioin of
exponential-phase cultures of EMT6 cells
with delay in subculture after ICRF 159
(200 ,ig/ml for 24 h) + X-irradiation. Lines
(li-awn by eye.
ICRF 1.59 has been shown to prevent
cells from entering mitosis (Taylor and
Bleehen, 1977). The possibility that ICRF
159-treated exponential cells might repair
PLD was therefore examined.
Fig. 5 shows the effect of delaying
subculture for varying times after a
single dose of radiation on drug-free
cells. As repair of radiation PLD is said
to be dose-dependent (Hahn and Little,
1972; Hahn et al., 1973), this was examined
using 3 different doses of radiation,
covering 3 log orders of cell kill. As was
expected, no repair of PLD was found
over the period examined in our expo-
nential cultures. W;rhen cells exposed to
IJRF 159 for 24 h before irradiation
were similarly examined (Fig. 6), again
no repair of PLD was observed. The
drug remained present during the delay
period. The surviving fractions shown in
Fig. 6 have not been normalized as,
over the time examined (i.e. 24-32 h)
no increase in cytotoxicity with time is
found (Taylor and Bleehen, 1977).
Repair of PLD is found when plateau-
phase cells are left in the plateau phase
of growth after irradiation (Little, 1969;
Hahn et al., 1973). We have investigated
the effect of ICRF 159 on the recovery
of radiation PLD in late plateau-phase
cultures. Late-plateau cells were produced
by seeding flasks with 05 cells and
feeding daily with fresh medium from
Day 2. The flasks were used in experi-
ments on Days 18 and 19.
Cells left in late plateau phase for 6 h
after a radiation dose of 1460 rad showed
a 10-fold increase in survival over similar
cells subcultured into fresh medium imme-
diately after irradiation (Fig. 7). Likewise
a 24 h ICRF 159 exposure before the
irradiation does not appear to inhibit
this repair process (Fig. 7). The drug
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FIG. 7. Change in surviving fraction of late
plateau-phase cultures of EMT6 cells with
delay in subculture. 0, X-irradiation alone
(1460 rad); 0, cells exposed to ICRF 159
(200 ,ug/ml) for 24 h before X-irradiation
(1240 rad). Line drawn by eye.
remained in the flasks for the interval
between irradiation and subculture. A
lower radiation dose of 1240 rad was
used with the drug-treated cells in order
to obtain surviving fractions similar to
those of radiation-only control cells.
It should be remarked that ICRF 159
has been shown to cause an increase in
the slope (Do) of the radiation response
curve for late-plateau cells without a
significant effect on the shoulder (Taylor
and Bleehen, 1977).
DISCUSSION.
ICRF 159 has been shown to potentiate
radiation in experimental tumours grown
in vtvo (Hellmann and -Murkin, 1974;
Norpoth et al., 1974). This has been
attributed to the drug's angiometamor-
phic action. The subsequent increase in
blood supply to the tumour might cause
an increase in 02 tension in the tumour
tissue, therefore presumably decreasing
the fraction of radioresistant hypoxic
cells (Norpoth et al., 1974). A further
possible mechanism of radiation poten-
tiation by ICRF 159 was demonstrated
when the drug was shown to potentiate
radiation killing in vitro (Taylor and
Bleehen, 1977).
In this paper we have shown that in
vitro radiation potentiation by ICRF
159 is only found when cells are exposed
to the drug for more than 10 h before
irradiation (Fig. 2). No such potentiation
is found when the drug is administered
afterirradiation (Fig. 3). Thetime sequence
of this effect cannot be readily explained.
We had thought that it might be due
to a drug-induced accumulation of cells
in the G2 phase of the cell cycle. If,
however, the point of accumulation was
particularly sensitive to radiation, a linear
decrease in surviving fraction with time
would be expected, which would only
reach a plateau when all cells had been
accumulated in the radiation-sensitive
phase. We have previously shown that
all cells in an exponentially growing
population (mean cell cycle time _ 12 h)
have accumulated in G2 after a 12-h
drug exposure (Taylor and Bleehen, 1977).
The results in Fig. 2, therefore, are
incompatible with the hypothesis that
the points of accumulation and of drug-
induced radiation sensitivity are one and
the same. We are currently engaged in
further studies using synchronized cells
in an attempt to elucidate the mechanisms
involved.
It is clear, however, that when poten-
tiation does occur, it is manifested as
a decrease in the radiation survival-curve
shoulder (Fig. 1). This shoulder is known
to be associated with the accumulation
and repair of sublethal damage (SLD)
(Elkind and Sutton, 1959). The observed
decrease in the shoulder, therefore, could
be due to:
(i) Inhibition of repair of sub-lethal
damage;
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However, the amount ofsub-lethaldamage
which cells can accumulate and thus
eventually repair is known to be propor-
tional to the extrapolation number (n)
(Hahn and Little, 1972). Cells cannot
A repair more sub-lethal damage than they
have the capacity to accumulate (Hahn,
1968). Expressing the split-dose results
as a recovery ratio (Fig. 8) does not take
into account the fact that a 24h exposure
* to ICRF 159 reduces the magnitude of
the radiation survival-curve shoulder (Fig.
1) and also the extrapolation number
(Table). As the measurement of Dq is
dependent on both extrapolation number
(n) and slope (Do) and ICRF 159 has
o 0 no significant effect on Do (Table), then
-0 8 Dq will reflect changes in n. Ifrestoration
of the shoulder of the radiation survival
curve, as measured by Dq, is taken as
, an indication of repair of sub-lethal
3 4 5 6 damage (Fig. 4), then ICRF 159 does
EEN DOSES (H) not appear to inhibit such repair. There-
ry ratio (seetext) of fore, the drug-treated cells may be ires of EMT6 cells expressing radiation damage with a small
2 doses of X-rays. radiation [on alone; A, cells survival-curve shoulder be- (200 ,ig/ml) for 6 h cause prior drug damage reduced their
RF X-irradiation; capacity to accumulate sub-lethal radia- EtF 159 (200 lAg/ml)
plit-dose X-irradia- tion damage.
re. This phenomenon has also been demon-
strated, under certain conditions, with
the capacity to other agents (e.g. actinomycin D (Piro,
lethal damage; Taylor and Belli, 1975) and 5-bromo-
of (i) and (ii). deoxyuridine (Shipley, Elkind and Pra- (i) an (ii). ther, 1971)).
Its from split-dose Normally, the effect of a drug on the
are expressed as ability of cells to accumulate sub-lethal
ie between doses. damage can be tested by comparing the
is defined as the surviving fractions obtained when the
resulting from a drug is given before or after the first
led by that result- dose of a two-dose radiation regime.
b1 dose delivered in However, because a prolonged ICRF 159
-n our results were treatment is required to achieve the
(Fig. 8), a 24 h reduction of the shoulder, it has not
P appeared signifi- been possible to do so with this drug.
)air of sub-lethal The absence of a potentiating effect
I with either a when given after irradiation (Fig. 3),
or radiation-only however, would tend to confirm that
rast to the absence ICRF 159 reduces the capacity to accu-
n the results are mulate sub-lethal damage rather than
recovery (Fig. 4). preventing repair. Other agents normally
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associated with repair ofSLD are effective
if given after irradiation (e.g. actinomycin
D: Elkind, Sakamoto and Kamper, 1968).
We have also shown that the ability
of ICRF 159 to cause cells to accumulate
in G2 does not lead to the repair of PLD
which might have led to erroneously
high estimates for the repair of SLD
(Fig. 6). However, in a system where
repair of PLD is possible, prolonged
treatment with ICRF 159 has no signifi-
cant effect on this repair process (Fig. 7).
In conclusion, it appears that pro-
longed exposure to ICRF 159 reduces
the cellular ability to accumulate sub-
lethal damage. We were unable to show
an effect on the repair processes for
sub-lethal or potentially lethal radiation
damage.
ICRF 159 was kindly supplied to us
by Dr A. Creighton and Professor K.
Hellmann ofthe Imperial Cancer Research
Fund Laboratories, London.
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